StonvexLoading…
StonvexStonvexStonvexCore line items from ONMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.36M | $643.00K | $1.02M | $1.15M |
Operating Income | $-9.67M | $-9.61M | $-6.85M | $-7.71M |
Net Income | $-2.80M | $-10.13M | $-33.78M | $-30.45M |
EPS (Diluted) | $-0.06 | $-0.36 | $-4.65 | $-7.66 |
Total Assets | $2.15M | $3.73M | $464.00K | $1.29M |
Total Liabilities | $5.12M | $19.68M | $13.91M | $27.65M |
Cash & Equivalents | $585.00K | $172.00K | $47.00K | $271.00K |
Free Cash Flow OCF − CapEx | $-7.52M | $-7.00M | $-4.83M | $-4.76M |
Shares Outstanding | 51.98M | 27.99M | 23.57M | 4.03M |